The possible associations between coronary heart disease (CHD) and peripheral arterial disease (PAD), detected by echo-Doppler analysis, with restriction fragment length polymorphism (RFLP) of apo AI/CIII cluster and apo B gene were investigated in a group of men with premature CHD (n = 39) and in a control group of men without evidence of CHD (n=40). The genetic analysis of SstI RFLP of apo AI/CIII cluster showed a significantly higher frequency of the rare SstI allele (S2) in CHD patients (0.16) as compared with controls (0.06). No significant differences were found in the frequencies of XbaI RFLP for the apo B gene between CHD patients and controls. Moreover, patients with PAD showed no significant differences in the frequencies of XbaI RFLP for the apo B gene and of SstI RFLP for the apo AI/CIII cluster as compared with patients without evidence of peripheral arterial disease detected by echo-Doppler analysis.
Get full access to this article
View all access options for this article.
References
1.
Hegele RA, Huang Li-S, Herbert P., et al: Apolipoprotein B gene DNA polymorphism associated with myocardial infarction. N Engl J Med315:1509-1515, 1986.
2.
Monsalve MV, Young R., Jobsis J., et al: DNA polymorphism of the gene for apolipoprotein B in patients with peripheral arterial disease. Atherosclerosis70:123-129, 1988.
3.
Myant NB, Gallagher J., Barbir M., et al: Restriction fragment length polymorphism in the apo B gene in relation to coronary artery disease. Atherosclerosis77:193-201, 1989.
4.
Genest JJ, Ordovas JM, McNamara JR, et al: DNA polymorphism of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis82:7-17, 1990.
5.
Wiklund O., Damfors C., Bjursell G., et al: Xbal restriction fragment length polymorphism of apolipoprotein B in Swedish myocardial infarction patients. Eur J Clin Invest19:255-258, 1989.
6.
Trembath RC, Thomas Djb, Hendra TJ, et al: Deoxyribonucleic acid polymorphism of the apoprotein AICIII-AIV gene cluster and coronary heart disease in non-insulin-dependent diabetes . Br Med J294:1577-1578, 1987 .
7.
Buraczynska M., Hanzlik J., Grzywa M., et al: Apo A-I related DNA polymorphism in humans with coronary heart disease. Hum Gen74:165-167, 1986.
8.
Rees A., Stocks J., Williams LC, et al: DNA polymorphism in the apolipoprotein C-III and insulin genes and atherosclerosis. Atherosclerosis58:269-275, 1985.
9.
Ferns Gaa, Ritchie C., Stocks J., et al: Genetic polymorphism of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancetii:300-303, 1985.
10.
Ferns GA, Galton DJ: Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis . Hum Gen73:245-249, 1986.
11.
O'Connor G. , Stocks J., Lumley J., et al: A DNA polymorphism of the apolipoprotein C-III gene in extra-coronary atherosclerosis. Clin Sci74:289-292, 1988.
12.
Ordovas JM, Civeira F., Genest J., et al: Restriction fragment length polymorphism of the apolipoprotein A-I, C-III, A-IV gene locus. Atherosclerosis87:75-86, 1991.
13.
Price WH, Kitchin AH, Burgon Prs, et al: DNA restriction fragment length polymorphism as markers of familial coronary heart disease. Lancetii: 1407-1411, 1989.
14.
Johansen K. , Dunn B., Tan Jce, et al: Coronary artery disease and apolipoprotein AI/CIII gene polymorphism: A study of Saudi Arabians. Clin Genet39:1-5, 1991.
15.
Paulweber B. , Friedl W., Krempler F., et al: Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease . Atherosclerosis73:125-133, 1988.
16.
Aalto-Setala K., Kontula K., Sane T., et al: DNA polymorphism of apolipoprotein A-I/CIII and insulin genes in familial hypertriglyceridemia and coronary heart disease. Atherosclerosis66:145-152, 1987.
17.
Karathanasis SK, Zannis VI, Breslow JL: Isolation and characterization of cDNA clones corresponding to two different human apo C-III alleles. J Lipid Res26:451-456, 1985.
18.
Protter A., Levy-Wilson B., Miller J., et al: Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo IA and apo CIII genes . DNA3:449-456, 1984.
19.
Oriente P., Di Marino L., Mastranzo P.: Simultaneous determination of cholesterol and triglycerides in serum and lipoprotein fraction by enzymatic automated methods. In: Clinical Enzymology Symposium 2, ed. by Galzigna AL.Padua: Piccin, pp 387-402.
20.
Saiki RK, Gelfand DH, Stoffel S., et al: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science239:487-491, 1988.
21.
Carlsson P., Damfors C., Oloffson S.O, et al: Analysis of human apolipoprotein B gene: Complete structure of the B-74 region. Gene49:29-51, 1986.
22.
Strandness DE : Noninvasive evaluation of arteriosclerosis. Comparison of methods. Arteriosclerosis3:103-116, 1983.
23.
Roederer GO, Langlois YE, Jager KA, et al: A simple spectral parameter for accurate classification of severe carotid disease. Bruit8:174-178, 1984.
24.
Rubba P., Faccenda F., De Simone B, et al: Validation of echo-Doppler for detection of iliac artery stenosis or occlusion. Atherosclerosis Rev12:185-191, 1984.
25.
Rees A., Stocks J., Shoulders CC, et al: DNA polymorphism adjacent to human apoprotein A-1 gene: Relation to hypertriglyceridaemia. Lanceti:444-446, 1983.
26.
Shoulders CC , Ball MJ, Mann JI, et al: Genetic marker in apolipoprotein AI/CIII gene complex associated with hypercholesterolaemia. Lancetii:1286, 1986.
